Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:INDGNFinancial Services
Clear all filters
Indegene Q4 net profit falls 32% despite record ₹1,003 crore revenue, declares dividend
positive
CNBC TV18 - Markets 72d ago

Indegene Q4 net profit falls 32% despite record ₹1,003 crore revenue, declares dividend

Shares of Indegene Ltd ended at ₹497.70, down by ₹2.05, or 0.41%, on the BSE.

BSEDIVIDENDINDGNFinancial ServicesHealthcare
Q4 Results Highlights: Indegene profit falls 32%, RPG Life revenue up 24%
positive
CNBC TV18 - Markets 72d ago

Q4 Results Highlights: Indegene profit falls 32%, RPG Life revenue up 24%

Q4 Results Highlights: Major companies including Bajaj Finance, Adani Power, Vedanta, MOIL, Mphasis, Navin Fluorine, Waaree Energies and Bandhan Bank reported their Q4 earnings on Wednesday, while a host of financial, energy and midcap firms also announced results, keeping markets active ahead of a holiday-shortened week.

ABSLBANETFADANIENSOLADANIENTADANIGREENADANIPOWERAUBANKBAJAJHFLBAJFINANCEBANDHANBNKBANKBETFBANKINDIACAPITALSFBDPELENERGYEQUITASBNKESAFSFBGKENERGYGVPILINDGNJMFINANCILJSFBKPELLTFMIDCAPMOILMPHASISNAVINFLUORPFCRPGLIFESURYODAYUJJIVANSFBUTKARSHBNKVEDLWAAREEENERCapital GoodsChemicals
Neutral Indegene; target of Rs 552: Motilal Oswal
positive
Moneycontrol NaNd ago

Neutral Indegene; target of Rs 552: Motilal Oswal

Motilal Oswal recommended Neutral rating on Indegene with a target price of Rs 552 in its research report dated May 02, 2026.

INDGNMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Indegene targets larger share of pharma marketing spend through acquisitions, AI
positive
Moneycontrol NaNd ago

Indegene targets larger share of pharma marketing spend through acquisitions, AI

The shift from the traditional pharma commercialisation model built around large sales forces, fragmented advertising agency networks and brand-by-brand marketing is giving way to centralised, data-driven and digital-first engagement, Indegene chief financial officer Suhas Prabhu tells Moneycontrol

INDGNJMFINANCILFinancial ServicesHealthcare